Next-generation inhibitors of SARS-CoV-2 Mpro overcome the deficiencies of Paxlovid.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41935038

Baisen Zhong; Chongbing Liao; Fan Wu; Gan Luo; Gang Wang; Jie Rao; Jue Zhang; Junjie Zhang; Lianfeng Fan; Lu Lu; Man Luo; Wei Xu; Wuyuan Lu; Xihui Gao; Yan Yan; Ziqiao Wang

Apr 5, 2026